Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Assembly Biosciences (ASMB) Assets Average (2016 - 2025)

Assembly Biosciences has reported Assets Average over the past 11 years, most recently at $248.8 million for Q4 2025.

  • Quarterly results put Assets Average at $248.8 million for Q4 2025, up 126.76% from a year ago — trailing twelve months through Dec 2025 was $248.8 million (up 126.76% YoY), and the annual figure for FY2025 was $188.4 million, up 47.18%.
  • Assets Average for Q4 2025 was $248.8 million at Assembly Biosciences, up from $160.4 million in the prior quarter.
  • Over the last five years, Assets Average for ASMB hit a ceiling of $281.1 million in Q1 2021 and a floor of $59.1 million in Q3 2023.
  • Median Assets Average over the past 5 years was $123.0 million (2024), compared with a mean of $149.7 million.
  • Biggest five-year swings in Assets Average: tumbled 55.39% in 2023 and later soared 126.76% in 2025.
  • Assembly Biosciences' Assets Average stood at $220.0 million in 2021, then crashed by 49.25% to $111.7 million in 2022, then dropped by 15.61% to $94.2 million in 2023, then rose by 16.44% to $109.7 million in 2024, then skyrocketed by 126.76% to $248.8 million in 2025.
  • The last three reported values for Assets Average were $248.8 million (Q4 2025), $160.4 million (Q3 2025), and $89.9 million (Q2 2025) per Business Quant data.